Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kevin McCowen"'
Autor:
Rukmini Reddy, Reshma Shringarpure, Shawn Shah, Emil Chuang, Sharat Singh, Kevin McCowen, Jared Salbato, Steven Lockton, Scott Hauenstein, Linda Ohrmund, S. T. Wang
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. :39-44
This report describes the analytical validation and application of the homogeneous mobility shift assay (HMSA) method for the measurement of adalimumab and human antibodies-to-adalimumab (ATA) in serum samples from patients who have lost response to
Autor:
Julie A. Hoyt, Carolyn M. Jodka, Bronislava Gedulin, David G. Parkes, Eric S. Kendall, Pamela A. Smith, A. Lwin, Christen M. Anderson, Kevin McCowen, Diane M. Hargrove, Shawn D. Flanagan, John Patrick Herich, James M. Reynolds
Publikováno v:
Regulatory Peptides. 141:113-119
Exenatide, the active ingredient of BYETTA (exenatide injection), is an incretin mimetic that has been developed for the treatment of patients with type 2 diabetes. Exenatide binds to and activates the known GLP-1 receptor with a potency comparable t
Autor:
Kathrin Copley, David G. Parkes, Richard Hiles, Loretta L. Nielsen, Andrew A. Young, Kevin McCowen
Publikováno v:
Current Drug Metabolism. 7:367-374
Exenatide is a 39 amino acid incretin mimetic for the treatment of type 2 diabetes, with glucoregulatory activity similar to glucagon-like peptide-1 (GLP-1). Exenatide is a poor substrate for the major route of GLP-1 degradation by dipeptidyl peptida
Autor:
Steven Lockton, Douglas C. Wolf, Rukmini Reddy, Emil Chuang, Kevin McCowen, Scott Hauenstein, Sharat Singh, Reshma Shringarpure, Shui Long Wang, Linda Ohrmund, Isam Diab, Shawn L. Shah, Jared Salbato
Publikováno v:
American Journal of Gastroenterology. 107:S680
Autor:
Kevin McCowen, Steven Lockton, Scott Hauenstein, Linda Ohrmund, S. T. Wang, Rukmini Reddy, Patrick Monk, Jared Salbato, Sharat Singh
Publikováno v:
Gastroenterology. 142:S-538